Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1460]

Essential breast cancer medicines

Dr Didier Verhoeven, Prof Helena Earl, Prof Ahmed Magdy and Prof Luiz Gebrim

Essential breast cancer medicines ( Dr Didier Verhoeven, Prof Helena Earl, Prof Ahmed Magdy and Prof Luiz Gebrim )

First-line use of tepotinib in METex14 NSCLC: A patient-centered journey

Dr Ryan Nguyen, Rebecca Timogtimog, Carmela Timogtimog

First-line use of tepotinib in METex14 NSCLC: A patient-centered journey ( Dr Ryan Nguyen, Rebecca Timogtimog, Carmela Timogtimog )

Empowering cancer care in Africa

Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo...

Empowering cancer care in Africa ( Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo, Mozambique and AORTIC President )

Do all hormone sensitive prostate cancers need triplet therapy?

Dr Deepak Dabkara - Tata Medical Center, Kolkata, India

Do all hormone sensitive prostate cancers need triplet therapy? ( Dr Deepak Dabkara - Tata Medical Center, Kolkata, India )

Panel Discussion: Case based discussions muscle invasive bladder cancer

Panelists: Dr Madhav Tiwari, Dr Tushar Dani, Dr Jaswant Jain, Dr Suneel Kaushik...

Panel Discussion: Case based discussions muscle invasive bladder cancer ( Panelists: Dr Madhav Tiwari, Dr Tushar Dani, Dr Jaswant Jain, Dr Suneel Kaushik, Dr Pradeep Chandrakar, Dr Puneet Seth, Dr Satvik Khaddar, Dr Azam Nawaz, Dr Aparna Sreevatsa, Dr Gaurav Gupta )

ESMO 2025: Latest in EGFR mutant NSCLC

Dr Alfredo Addeo, Prof Nicolas Girard, Dr Anna Minchom and Prof Pascale Tomasini

ESMO 2025: Latest in EGFR mutant NSCLC ( Dr Alfredo Addeo, Prof Nicolas Girard, Dr Anna Minchom and Prof Pascale Tomasini )

Improving efficacy and toxicity reporting - and treatment insights from an...

Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado

Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient ( Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado )

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG

Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG ( Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA )

Memorial Cancer Institute's Best of ASCO® 2025

Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA

Memorial Cancer Institute's Best of ASCO® 2025 ( Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA )

Updates on gastrointestinal cancer treatments ASCO 2025

Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA

Updates on gastrointestinal cancer treatments ASCO 2025 ( Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA )

Latest advances in chronic lymphocytic leukaemia

Dr Jose Sandoval Sus - Moffitt Malignant Hematology & Cellular Therapy at...

Latest advances in chronic lymphocytic leukaemia ( Dr Jose Sandoval Sus - Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Florida, USA )

(Bio) Markers and milestones at the crossroads of mHSPC care 

Dr Miguel Ramírez-Backhaus, Prof Jozefina Casuscelli, Prof Gerhardt Attard

(Bio) Markers and milestones at the crossroads of mHSPC care  ( Dr Miguel Ramírez-Backhaus, Prof Jozefina Casuscelli, Prof Gerhardt Attard )

More from ecancer